HMG-CoA reductase inhibitors (Yeungnam University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHMG-CoA reductase inhibitors (Yeungnam University)
Drug Alias Nameatherosclerosis therapies (Yeungnam University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYeungnam University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYeungnam University
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A